BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9525448)

  • 1. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
    Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
    J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid.
    Durham SR; Gould HJ; Thienes CP; Jacobson MR; Masuyama K; Rak S; Lowhagen O; Schotman E; Cameron L; Hamid QA
    Eur J Immunol; 1997 Nov; 27(11):2899-906. PubMed ID: 9394816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy.
    Till SJ; Jacobson MR; O'Brien F; Durham SR; KleinJan A; Fokkens WJ; Juliusson S; Löwhagen O
    Allergy; 2001 Feb; 56(2):126-31. PubMed ID: 11167372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure.
    Cameron L; Hamid Q; Wright E; Nakamura Y; Christodoulopoulos P; Muro S; Frenkiel S; Lavigne F; Durham S; Gould H
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):46-52. PubMed ID: 10887304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
    Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.
    Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
    Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
    Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
    Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
    Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S
    Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.
    Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q
    J Allergy Clin Immunol; 1997 Oct; 100(4):569-74. PubMed ID: 9338554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
    Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
    Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of IgE heavy chain transcripts in the sinus mucosa of atopic and nonatopic patients with chronic sinusitis.
    Ghaffar O; Durham SR; Al-Ghamdi K; Wright E; Small P; Frenkiel S; Gould HJ; Hamid Q
    Am J Respir Cell Mol Biol; 1998 May; 18(5):706-11. PubMed ID: 9569241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
    Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
    Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.